HIV positive patients should not delay seeking treatment, an international major study said, medication should be started soon after diagnosis to make people live healthier longer.
HIV positive patients who started taking anti-AIDS drugs while they still have strong immune system were less likely to develop AIDS and other serious diseases compared to waiting for their immune system to weaken, announced the U.S. National Institutes of Health on Wednesday.
Although, the findings are still preliminary, the NIH considered them so convincing it stopped the study a year earlier, so that all the participants would be able receive medication as researchers track their health.
The treatment should begin “the sooner the better,”said the director of NIH’s National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci.
Even though HIV does not elicit symptoms for years, the question of how soon after diagnosis would and HIV patient begin to take medications which can cause side effects.
The START trial (Strategic Timing of Anti Retroviral Treatment) seeks proof by assigning still healthy patients to receive early therapy or opting to delay therapy until CD4 cells, a crucial mark of the health of the immune system, dropped into an alarming level.
While the U.S. healthcare support treatment notwithstanding of the CD4 count of patients, the WHO guidelines endorse that HIV-positive people should begin treatment when CD4 levels fall below normal. But that does not occur in a number of poor nations, where people often get sicker before receiving treatment since global funding to expand health care is tight.
Even in the U.S., a lot of people do not seek early medical attention. The Centers for Disease Control and Prevention reported recently only around 30% Americans with HIV have the virus under control.